Predictors of rituximab efficacy in systemic sclerosis-associated interstitial lung disease: machine-learning analysis of the DESIRES trial
Even slight elevations in serum CRP levels are associated with the improvement in ppFVC and may serve as predictors of rituximab efficacy in SSc-ILD.
Authors
- Ai Kuzumi (ORCID: https://orcid.org/0000-0003-2261-7469)
- Yukari Uemura (ORCID: https://orcid.org/0000-0002-3013-7775)
- Kosuke Kashiwabara (ORCID: https://orcid.org/0000-0003-3103-8055)
- Koji Oba (ORCID: https://orcid.org/0000-0001-5468-8988)
- Ayumi Yoshizaki (ORCID: https://orcid.org/0000-0002-8194-9140)
- Asako Yoshizaki‐Ogawa (ORCID: https://orcid.org/0000-0002-8896-479X)
- Keiko Ueda (ORCID: https://orcid.org/0000-0002-4830-4607)
- Shunsuke Miura (ORCID: https://orcid.org/0000-0001-7259-2242)
- Takemichi Fukasawa (ORCID: https://orcid.org/0000-0002-6093-1881)
- Takeyuki Watadani (ORCID: https://orcid.org/0000-0002-3587-9356)
- Satoshi Ebata (ORCID: https://orcid.org/0000-0001-5606-1513)
- Hidenori Kage
- Shinichi Sato
Institutions
- Tokyo University of Technology (JP)
- National Center for Global Health and Medicine (JP)
- University of Tokyo Hospital (JP)
- Center for Global Health (US)
- The University of Tokyo (JP)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1093/rheumatology/keae716
- Citations
- 4
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.70